journal article·2026-07-20Open access

A Supramolecular Thermal Switch for Precision Pyroptosis via Host−Guest Recognition and Electrostatic Interactions

Dan Wu, Jie Zhou, Yibin Cao, Kunmin Ping, Borui Zhao, Yanrong Yang, Chunyang Yu, Xinyang Yu, Shaolong Qi

Abstract

ABSTRACT Cytomembrane‐puncturing gasdermin (GSDM)‐mediated pyroptosis activates antitumor immunity through the release of immunogenic cellular contents and proinflammatory cytokines. However, programmable and precise pyroptosis remains challenging due to the rigidity, inefficiency, and systemic toxicity of conventional inducers. Herein, a supramolecular thermal switch is engineered to enable precision pyroptosis induction. Triiodide ions (I 3 − ) are stabilized within β‐cyclodextrin ( β‐CD ) via host–guest recognition, enhancing payload efficiency and bioavailability, while calcium ions (Ca 2 + ), anchored on the periphery of β‐CD through electrostatic Ca 2 + /carboxylate interactions, nucleate CaCO 3 crystal growth. The resulting CaCO 3 matrix acts as a sustained Ca 2+ reservoir while preventing premature leakage of both Ca 2+ and I 3 − . In the acidic tumor microenvironment, CaCO 3 decomposes, enabling site‐specific release of I 3 − and Ca 2+ via a pH‐responsive disassembly mechanism. Under spatiotemporally controlled near‐infrared (NIR) laser irradiation, the boron dipyrromethene (BODIPY)‐based thermal switch is activated, converting biocompatible I 3 − into toxic iodine (I 2 ) and triggering a cascade of intracellular oxidative stress, mitochondrial damage and calcium buffer collapse. Synergizing with dysregulated Ca 2 + homeostasis, exogenous Ca 2 + burst induces Ca 2 + overload and cysteine‐aspartic acid protease‐3 (caspase‐3)/GSDME‐mediated pyroptosis, thereby connecting innate and adaptive immunity to inhibit tumor growth and metastasis. This supramolecular engineering strategy presents a promising approach for potentiating cancer immunotherapy.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Inflammasome and immune disorders · Pericarditis and Cardiac Tamponade · interferon and immune responses

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

State Key Laboratory of Advanced Separation Membrane Materials Zhejiang Key Laboratory of Advanced Polymer Materials Modification and Application Technology College of Materials Science and Engineering Zhejiang University of Technology Hangzhou P. R. China

State Key Laboratory of Synergistic Chem‐Bio Synthesis School of Chemistry and Chemical Engineering Shanghai Key Laboratory of Electrical Insulation and Thermal Aging Shanghai Jiao Tong University Shanghai P. R. China

Department of Chemistry Ministry of Education Key Laboratory of Bioorganic Phosphorus Chemistry & Chemical Biology Tsinghua University Beijing P. R. China

Funding

National Natural Science Foundation of China · China Postdoctoral Science Foundation

References (35)

Show source-provided references
1. 10.1038/s41565‐022‐01125‐010.1038/s41565‐022‐01125‐0 ↗
2. 10.1038/s41467‐019‐09397‐210.1038/s41467‐019‐09397‐2 ↗
3. 10.1002/anie.20201028110.1002/anie.202010281 ↗
4. 10.1016/j.biomaterials.2023.12229310.1016/j.biomaterials.2023.122293 ↗
5. 10.1016/j.biomaterials.2024.12302710.1016/j.biomaterials.2024.123027 ↗
6. 10.1021/acsnano.2c1083010.1021/acsnano.2c10830 ↗
7. 10.1002/adma.20200208510.1002/adma.202002085 ↗
8. 10.1038/s41589‐020‐00693‐310.1038/s41589‐020‐00693‐3 ↗
9. 10.1021/acsnano.1c0949610.1021/acsnano.1c09496 ↗
10. 10.3390/ijms2203122810.3390/ijms22031228 ↗
11. 10.3390/biom1110150110.3390/biom11101501 ↗
12. 10.1021/acsnano.2c0176410.1021/acsnano.2c01764 ↗
13. 10.1021/acsami.9b2098110.1021/acsami.9b20981 ↗
14. 10.1039/C7CS00391A10.1039/C7CS00391A ↗
15. 10.1002/anie.20180657510.1002/anie.201806575 ↗
16. 10.1039/D3CS00516J10.1039/D3CS00516J ↗
17. 10.1038/nchem.220610.1038/nchem.2206 ↗
18. 10.1038/nnano.2014.33710.1038/nnano.2014.337 ↗
19. 10.1038/s41586‐025‐08833‐210.1038/s41586‐025‐08833‐2 ↗
20. 10.1021/jacs.4c1442410.1021/jacs.4c14424 ↗
21. 10.1038/s41467‐025‐56308‐910.1038/s41467‐025‐56308‐9 ↗
22. 10.1021/jacs.4c1484710.1021/jacs.4c14847 ↗
23. 10.1021/jacs.8b0440010.1021/jacs.8b04400 ↗
24. 10.1021/jacs.3c0303110.1021/jacs.3c03031 ↗
25. 10.1038/s41551‐023‐01147‐610.1038/s41551‐023‐01147‐6 ↗
26. 10.1002/advs.20230997610.1002/advs.202309976 ↗
27. 10.1002/anie.20231632310.1002/anie.202316323 ↗
28. 10.1039/D1CS00821H10.1039/D1CS00821H ↗
29. 10.1007/s00216‐004‐3004‐410.1007/s00216‐004‐3004‐4 ↗
30. 10.3390/pharmaceutics1307095510.3390/pharmaceutics13070955 ↗
31. 10.1002/advs.20240851810.1002/advs.202408518 ↗
32. 10.1002/anie.20160136410.1002/anie.201601364 ↗
33. 10.1021/acsnano.3c0556310.1021/acsnano.3c05563 ↗
34. 10.1038/s41467-023-42740-210.1038/s41467-023-42740-2 ↗
35. 10.1038/s41589‐023‐01512‐110.1038/s41589‐023‐01512‐1 ↗